PortfoliosLab logoPortfoliosLab logo
GUSH vs. CURE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GUSH vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily S&P Oil & Gas Exploration & Production Bull 2x Shares (GUSH) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GUSH achieves a 61.19% return, which is significantly higher than CURE's -7.96% return. Over the past 10 years, GUSH has underperformed CURE with an annualized return of -36.52%, while CURE has yielded a comparatively higher 13.49% annualized return.


GUSH

1D
2.06%
1M
-5.00%
YTD
61.19%
6M
49.15%
1Y
49.53%
3Y*
8.93%
5Y*
9.46%
10Y*
-36.52%

CURE

1D
-0.55%
1M
13.53%
YTD
-7.96%
6M
-6.00%
1Y
26.46%
3Y*
3.05%
5Y*
1.51%
10Y*
13.49%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GUSH vs. CURE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
GUSH
Direxion Daily S&P Oil & Gas Exploration & Production Bull 2x Shares
61.19%-19.39%-12.73%-7.23%66.47%129.94%-97.38%-52.68%-74.28%-40.21%
CURE
Direxion Daily Healthcare Bull 3x Shares
-7.96%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%

Correlation

The correlation between GUSH and CURE is -0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.08

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.18

Correlation (10Y)
Calculated over the trailing 10-year period

0.25

Correlation (All Time)
Calculated using the full available price history since May 29, 2015

0.27

The correlation between GUSH and CURE shifts across timeframes, from -0.08 (1 year) to 0.27 (all time), reflecting how their relationship changes across market environments.

GUSH vs. CURE - Sectors Allocation Comparison


Sectors
GUSH
CURE

Energy

97.2%

-

Basic Materials

2.9%

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Financial Services

-

-

Healthcare

-

100.0%

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Energy

GUSH
97.2%
CURE

-

Basic Materials

GUSH
2.9%
CURE

-

Communication Services

GUSH

-

CURE

-

Consumer Cyclical

GUSH

-

CURE

-

Consumer Defensive

GUSH

-

CURE

-

Financial Services

GUSH

-

CURE

-

Healthcare

GUSH

-

CURE
100.0%

Industrials

GUSH

-

CURE

-

Real Estate

GUSH

-

CURE

-

Technology

GUSH

-

CURE

-

Utilities

GUSH

-

CURE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GUSH vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GUSH
GUSH Risk / Return Rank: 3131
Overall Rank
GUSH Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
GUSH Sortino Ratio Rank: 2828
Sortino Ratio Rank
GUSH Omega Ratio Rank: 2828
Omega Ratio Rank
GUSH Calmar Ratio Rank: 4040
Calmar Ratio Rank
GUSH Martin Ratio Rank: 3030
Martin Ratio Rank

CURE
CURE Risk / Return Rank: 2121
Overall Rank
CURE Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 2424
Sortino Ratio Rank
CURE Omega Ratio Rank: 2222
Omega Ratio Rank
CURE Calmar Ratio Rank: 2222
Calmar Ratio Rank
CURE Martin Ratio Rank: 1919
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GUSH vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Oil & Gas Exploration & Production Bull 2x Shares (GUSH) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GUSHCUREDifference
Sharpe ratioReturn per unit of total volatility

+0.29

Sortino ratioReturn per unit of downside risk

+0.22

Omega ratioGain probability vs. loss probability

1.17

1.13

+0.04

Calmar ratioReturn relative to maximum drawdown

1.72

0.85

+0.87

Martin ratioReturn relative to average drawdown

3.77

1.94

+1.84

GUSH vs. CURE - Sharpe Ratio Comparison

The current GUSH Sharpe Ratio is 0.89, which is higher than the CURE Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of GUSH and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GUSH vs. CURE - Drawdown Comparison

The maximum GUSH drawdown since its inception was -99.98%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for GUSH and CURE.


Loading charts...

Drawdown Indicators


GUSHCUREDifference

Max Drawdown

Largest peak-to-trough decline

-99.98%

-69.19%

-30.79%

Max Drawdown (1Y)

Largest decline over 1 year

-28.94%

-31.10%

+2.16%

Max Drawdown (3Y)

Largest decline over 3 years

-63.59%

-51.93%

-11.66%

Max Drawdown (5Y)

Largest decline over 5 years

-73.64%

-52.23%

-21.41%

Max Drawdown (10Y)

Largest decline over 10 years

-99.94%

-69.19%

-30.75%

Current Drawdown

Current decline from peak

-99.80%

-26.94%

-72.86%

Average Drawdown

Average peak-to-trough decline

-92.90%

-18.16%

-74.74%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.16%

13.71%

-0.55%

Volatility

GUSH vs. CURE - Volatility Comparison

Direxion Daily S&P Oil & Gas Exploration & Production Bull 2x Shares (GUSH) has a higher volatility of 18.07% compared to Direxion Daily Healthcare Bull 3x Shares (CURE) at 14.30%. This indicates that GUSH's price experiences larger fluctuations and is considered to be riskier than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GUSHCUREDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.07%

14.30%

+3.77%

Volatility (6M)

Calculated over the trailing 6-month period

44.41%

30.87%

+13.54%

Volatility (1Y)

Calculated over the trailing 1-year period

56.06%

44.32%

+11.74%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

68.35%

43.84%

+24.51%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

93.58%

49.59%

+43.99%

GUSH vs. CURE - Expense Ratio Comparison

GUSH has a 1.17% expense ratio, which is higher than CURE's 1.08% expense ratio.


Dividends

GUSH vs. CURE - Dividend Comparison

GUSH's dividend yield for the trailing twelve months is around 1.55%, more than CURE's 1.16% yield.


PositionTTM2025202420232022202120202019201820172016
CURE
Direxion Daily Healthcare Bull 3x Shares
1.16%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%0.00%
GUSH
Direxion Daily S&P Oil & Gas Exploration & Production Bull 2x Shares
1.55%2.60%2.96%3.00%0.47%0.00%0.20%1.68%0.17%0.00%3.26%

Frequently Asked Questions


GUSH and CURE have a correlation of -0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GUSH has higher volatility (18.07%) compared to CURE (14.30%). In terms of maximum drawdown, GUSH dropped -99.98% vs CURE's -69.19%.

On 10-year performance, CURE leads with 13.49% vs -36.52% for GUSH. On fees, CURE is cheaper at 1.08% per year. On volatility, CURE has been the lower-risk option at 14.30%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, CURE has performed better with a 13.49% return vs -36.52%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

CURE is cheaper with a 1.08% expense ratio, compared with 1.17% for GUSH.

GUSH has the higher dividend yield at 1.55%, compared with 1.16% for CURE.

GUSH tracks S&P Oil & Gas Exploration & Production Select Industry Index (300%), while CURE tracks Health Care Select Sector Index (300%). Their fees differ too: 1.17% for GUSH and 1.08% for CURE.

GUSH currently has the higher Sharpe Ratio (0.89 vs 0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GUSH and CURE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer